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he apical surface of mouse urothelium is covered by
two-dimensional crystals (plaques) of uroplakin
(UP) particles. To study uroplakin function, we ab-
lated the mouse UPII gene. A comparison of the pheno-
types of UPII- and UPIII-deﬁcient mice yielded new insights
into the mechanism of plaque formation and some funda-
mental features of urothelial differentiation. Although
UPIII knockout yielded small plaques, UPII knockout
abolished  plaque formation, indicating that both
uroplakin heterodimers (UPIa/II and UPIb/III or IIIb) are
required for plaque assembly. Both knockouts had elevated
T
 
UPIb gene expression, suggesting that this is a general
response to defective plaque assembly. Both knockouts
also had small superﬁcial cells, suggesting that continued
fusion of uroplakin-delivering vesicles with the apical
surface may contribute to umbrella cell enlargement. Both
knockouts experienced vesicoureteral reﬂux, hydro-
nephrosis,  renal dysfunction, and, in the offspring of
some breeding pairs, renal failure and neonatal death.
These results highlight the functional importance of
uroplakins and establish uroplakin defects as a possible
cause of major urinary tract anomalies and death.
 
Introduction
 
The apical surface of mammalian urothelium that is in contact
with the urine is highly specialized, featuring two-dimensional
(2D) crystals (urothelial plaques) of hexagonally packed 16-nm
protein particles (Hicks and Ketterer, 1969; Vergara et al.,
1969; Staehelin et al., 1972; Brisson and Wade, 1983; Walz et
al., 1995; Kachar et al., 1999; Oostergetel et al., 2001; Min et
al., 2003). These plaques contain four major uroplakins (UPs):
Ia (27 kD), Ib (28 kD), II (15 kD), and III (47 kD) (Wu et al.,
1994; Sun et al., 1999). Uroplakins Ia and Ib have four trans-
membrane domains, are 
 
 
 
40% identical in sequence, and belong
to the “tetraspanin” family (Yu et al., 1994). The tetraspanin
family contains many cell surface molecules, including CD9,
CD63, CD81, CD82, and CD151, that play key roles in cellular
events involving membrane organization (Maecker et al., 1997;
Levy et al., 1998; Berditchevski, 2001; Boucheix and Rubinstein,
2001; Hemler, 2001, 2003; Tarrant et al., 2003; Yunta and
Lazo, 2003). Uroplakins II and III both have a single trans-
membrane domain, and they share a common stretch of 
 
 
 
12
amino acid residues on the exoplasmic side of the transmem-
brane domain (Wu and Sun, 1993; Lin et al., 1994; Deng et al.,
2002). Within the plaques, these four major uroplakins are
organized into two heterodimers consisting of Ia/II and Ib/III,
as demonstrated by chemical cross-linking (Wu et al., 1995)
and protein isolation (Liang et al., 2001). In addition, transfection
studies show that when individual uroplakins are expressed in
293T cells, they are retained in the ER; however, coexpression
of uroplakins Ia plus II or Ib plus III permits the heterodimers
to exit from the ER; these events suggest that the formation of
specific heterodimers is a prerequisite for uroplakins to reach
the cell surface (Tu et al., 2002).
To study the functional and disease implications of
uroplakins, we previously generated uroplakin III–deficient
mice using the gene-targeting approach (Hu et al., 2000). Such
mice lack a typical urothelial umbrella cell layer. They have a
reduced urothelial plaque size, compromised urothelial perme-
ability barrier function, and retrograde flow of urine from
the bladder into the ureters (vesicoureteral reflux [VUR]). In
 
 
 
70% of the mice, accumulation of urine in the renal pelvis
(hydronephrosis) occurs (Hu et al., 2000, 2002). These results
establish that uroplakin III is an integral subunit of urothelial
plaques, which contribute to the permeability barrier function
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of the urothelial apical surface, and suggest that urothelial de-
fects may play a role in VUR (Hu et al., 2000, 2002).
Some of the phenotypes of these UPIII-deficient mice re-
main hardly understood. For example, the observation that
UPIII deficiency leads to the formation of small plaques seems
incompatible with our current assumption that all four major
uroplakins are required for the formation of the 16-nm particle
(Sun et al., 1999). One possible explanation is that UPIIIb, a
newly discovered, minor UPIII isoform (Deng et al., 2002), is
responsible for the formation of the residual plaques observed
in the UPIII-deficient urothelium. If it is, one would predict
that knockout of uroplakin II, which does not have a known
isoform, should completely abolish plaque formation. Another
question has to do with the possible role of uroplakin mutation
in VUR. Although knockout of the UPIII gene leads to VUR in
mice, screening of human VUR patients revealed that polymor-
phism of uroplakin genes is only marginally associated with
VUR (Giltay et al., 2004; Jiang et al., 2004). Moreover, al-
though polymorphism was found in these VUR patients, no de-
letion, truncation, or frameshift mutations have been detected
so far (Giltay et al., 2004; Jiang et al., 2004). The role of
uroplakin defects in VUR and other lower urinary tract anoma-
lies thus remains unclear.
To address these issues, we have genetically ablated the
mouse UPII gene to perturb the other uroplakin pair consisting
of UPIa/II. This led to the entrapment of UPIa in the ER, but al-
lowed the remaining UPIb/III pair to reach the apical urothelial
surface. No 16-nm particle or apical plaques were formed,
however, which indicates that both uroplakin heterodimers
were required for plaque formation. The small size of the su-
perficial cells in both UPII- and UPIII-deficient urothelia sug-
gested that the incorporation of fully assembled uroplakin
plaques into the apical surface through fusion of the fusiform
vesicles with the apical membrane played a role in the enlarge-
ment of umbrella cells. Because entire litters of UPII-deficient
mice from some breeding pairs (originating from the inbred
129/SvEv and outbred Swiss Webster strains) reproducibly
died 8–10 d postnatally, as a result of renal failure, it seems that
major uroplakin defects such as gene deletion, frameshift, or
truncation might cause urinary tract anomalies that, in severe
cases, could lead to death. These results highlight the critical
functional importance of uroplakins in the formation of a spe-
cialized urothelial apical surface, and shed light on the mecha-
nisms of plaque formation, umbrella cell enlargement, and cer-
tain urinary tract abnormalities.
 
Results
 
Inactivation of the mouse uroplakin II 
gene
 
After transfecting embryonic stem (ES) cells (from 129/SvEv
mice) with a vector designed to delete the first four exons and a
part of the fifth exon of the mouse uroplakin II gene (Fig. 1 A),
we screened 320 ES cell colonies and found 4 that were harbor-
ing the correct homologous recombination events as determined
by long template PCR (Fig. 1 B) and Southern blot (not de-
picted). 18 chimeric mice from three ES cell lines were germ-
line transmitting and were bred with black Swiss Webster mice
to yield homozygous UPII knockout mice. Northern (Fig. 1, C
and D) and Western (Fig. 1 E) blotting confirmed the absence
of UPII in homozygous uroplakin II–deficient (
 
 
 
/
 
 
 
) mice. The
Figure 1. Inactivation of the mouse UPII gene (upk2) perturbed the
expression of other uroplakins. (A) Alignment of the mouse UPII locus, the
targeting vector (V), and the mutated locus (KO). Black boxes, exons; thick
lines, mouse genomic sequences included in the vector; crosses, potential
crossover sites; PCR1 and 2, PCR products characteristic of the wild-type and
KO alleles, respectively; Neo, neomycin-resistant gene; TK, thymidine kinase
of the herpes simplex virus; B, BamHI; C, ClaI; E, EcoRI; S, SacI; X, Xhol. (B)
PCR analysis of the genomic DNA using a mixture of two pairs of primers that
generated 4.0-kb and 3.8-kb PCR products characteristic of the wild-type ( )
and KO ( ) alleles, respectively. M,  C, and  C denote size markers, posi-
tive controls ( /  genomic DNA or vector used as templates), and a nega-
tive control (no template), respectively. (C) Northern blot analysis. 5  g of total
RNA samples was resolved electrophoretically and probed with cDNA of
mouse uroplakins Ia, Ib, II, and III, and glyceraldehyde phosphate dehydro-
genase (GAPDH) as a loading control. Note, in the  /  animals, the
absence of UPII message and the  2  and 10–20  increases in UPIa and
UPIb message, respectively. (D) Ethidium bromide–stained rRNA of the sam-
ples in C serving as a loading control. (E) Immunoblot analysis of mouse
uroplakin proteins Ia (27 kD), Ib (28 kD), II (15 kD), and III (47 kD). FG
denotes the fast green–stained total mouse urothelial proteins used for immuno-
blotting. MAPK and tubulin of the same samples were immunoblotted for
comparison. Note in the  /  mice the absence of UPII protein, the significant
decrease in the levels of the other three uroplakin proteins, and the absence
of the highest mol wt ( 30 kD) UPIb species due to defective glycosylation. 
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protein levels of uroplakin Ia, UPII’s partner, and of uroplakins
Ib and III (of the uroplakin Ib/III pair) were reduced 10–20-fold
(on a per total cellular protein basis) when compared with those
of the normal control mice (
 
 
 
/
 
 
 
; Fig. 1 E). The mRNA levels
of UPIa and UPIII were slightly up-regulated (about twofold),
whereas that of UPIb was drastically up-regulated by 10–20-
fold (Fig. 1 C; see Discussion).
 
Uroplakin expression and plaque 
formation
 
Consistent with the UPIII knockout results, the UPII-deficient
urothelium lacked a typical superficial umbrella cell layer (Fig.
2 b). This urothelium was hyperplastic, as indicated by an ele-
vated level of BrdU incorporation (the labeling index increased
almost 100-fold from 0.12%, which is normal, to 10.7%; Fig.
2, c and d), and was three- to sixfold thicker than normal (Fig.
2, a and b). Immunohistochemical staining with monospecific
rabbit and mouse antibodies to individual uroplakins confirmed
that all four major uroplakins were preferentially expressed in
superficial umbrella cells in normal mouse urothelium (Fig. 3,
a, c, e, g, and i; Hu et al., 2000). The staining of the UPII-defi-
cient urothelium showed that UPIa (the partner of UPII) was
diffusely distributed in all upper cells, which is consistent with
its entrapment in the ER (Fig. 3 d). Uroplakins Ib and III (of the
other uroplakin pair), although expressed at a lower level than
normal, were clearly associated with the apical, as well as some
basal/lateral, cell surface(s) (Fig. 3, f and j).
Unlike normal urothelium, which was covered by large
squamous superficial umbrella cells that could be as large as
100 
 
 
 
m in diameter (Fig. 4 a) and were covered by rigid-look-
Figure 2. UPII-deficient urothelium lacked a typical umbrella cell layer
and became hyperplastic. Paraffin sections of the normal (a) and UPII-deficient
(b) bladders of 1-mo-old male mice were stained with hematoxylin and
eosin. Those of normal (c) and UPII-deficient (d) bladders of 19-day-old
male mice were isolated 2 hr after the final i.p. injection of BrdU and were
stained immunohistochemically for BrdU. The inset in c shows an area
with some BrdU-incorporating superficial cells. Note the increased thick-
ness and the elevated BrdU incorporation (10.7   1.1% vs. 0.12  
0.07%) of the UPII-deficient urothelium. Also note that although most of the
labeling occurred in basal cells (arrows), there was occasional labeling of
superficial cells (arrowheads). A total of eight UPII-deficient mice and eight
normal mice, half of them male, were studied; 1,000–2,000 urothelial
cells were examined per section from each animal; P   0.001; with no
significant gender differences. Bar, 50  m.
Figure 3. Altered uroplakin expression pattern in the UPII-deficient
urothelium. Paraffin sections of wild-type (WT; a, c, e, g, and i) or UPII-
deficient (UPII KO; b, d, f, h, and j) mouse urothelium were immunohis-
tochemically stained for keratins (a and b) using a mixture of AE1 and
AE3 mouse monoclonal antibodies (Tseng et al., 1982; for review see
Cooper et al., 1985), uroplakin Ia (c and d), UPIb (e and f), UPII (g and
h), and UPIII (i and j). k shows the silver nitrate–stained (SN) SDS-PAGE
patterns of the detergent-insoluble membrane proteins from (lanes 1)
bovine urothelium, (2) normal mouse urothelium, (3) UPIII-deficient
mouse urothelium, and (4) UPII-deficient mouse urothelium, and the immuno-
blotting of these proteins using antibodies to UPs Ia, Ib, II, IIIa, and IIIb.
Note, in the thickened UPII KO urothelium, the absence of UPII, the dif-
fused cytoplasmic distribution and lack of apical surface association of
UPIa, the greatly reduced but still noticeably apical surface association
(arrowheads) of UPIb and UPIII, and the reduced amounts of detergent-
insoluble uroplakins in the UPIII-deficient urothelium (lanes 3) and their
further reduction in the UPII-deficient urothelium (lanes 4). Bar, 50  m.
 
ing plaques (Figs. 4 c and 5 a), superficial cells of the UPII-
deficient urothelium were uniformly small (20–30 
 
 
 
m; Fig.
4 b) and were completely devoid of the rigid-looking, apical 
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plaques (Fig. 4 d). In addition, the uroplakin-delivering fusi-
form vesicles (0.7–1 
 
 
 
m in diameter; Fig. 5 a) were totally re-
placed by numerous small, spherical vesicles (Fig. 5 b). These
small vesicles (150–200 nm in diameter) in the UPIII- and
UPII-deficient urothelia were moderately and weakly labeled,
respectively, by antibodies to uroplakins (Fig. 5, e–h), which
indicates that they were involved in delivering the remaining
uroplakins to the cell surface. Consistent with these findings,
the detergent-insoluble membrane fraction of the UPIII-defi-
cient mouse urothelium showed a significantly reduced number
of uroplakins (Fig. 3 k, lanes 3), whereas that of the UPII-defi-
cient urothelium contained almost no detectable uroplakins
(Fig. 3 k, lanes 4). Together, these results indicated that UPII
ablation completely abolished plaque formation.
 
VUR, ureteral obstruction, and 
hydronephrosis
 
By administering an India ink solution into the bladders of live,
anesthetized mice (Fig. 6, a and b), we determined the hydro-
static pressures at which micturition (P
 
M
 
) and VUR (P
 
R
 
) oc-
curred. Normal mice had a P
 
M
 
 of 28 cm of H
 
2
 
O pressure (Fig. 6
c), and most of them did not reflux—unless the urethra was li-
gated, causing outlet obstruction, and the hydrostatic pressure
was increased to 40–80 cm of H
 
2
 
O (Fig. 6 d, WT). Although
the UPII knockout mice had a normal micturition pressure of
 
 
 
24 cm of H
 
2
 
O (Fig. 6 c), 
 
 
 
50% (11 out of 20) of the mice re-
fluxed at a pressure lower than this (Fig. 6, d and e). Many
of the (
 
 
 
/
 
 
 
) mice developed severe hydronephrosis with a
greatly expanded renal pelvis (Fig. 7, b and d) and associ-
ated renal morphological changes (Fig. 7, a–f). To determine
whether reflux caused hydronephrosis, we calculated the dif-
ference between the P
 
M
 
 and the P
 
R
 
 of each ureter (P
 
K
 
 [hydro-
static pressure to the kidney] 
 
 
 
 P
 
M
 
 
 
 
 
 P
 
R
 
). For a normal mouse
that had a P
 
M
 
 of 25 cm of H
 
2
 
O and a P
 
R
 
 of 50 cm, an intravesic-
ular pressure of 
 
 
 
25 cm of H
 
2
 
O would result in micturition and
dissipation of pressure. However, for a UPII knockout mouse
that had a P
 
M
 
 of 25 cm of H
 
2
 
O but a lower P
 
R
 
 of 18 cm of H
 
2
 
O,
intravesicular pressures of 18–25 cm of H
 
2
 
O would lead to re-
flux, thus potentially transmitting up to 7 cm of hydrostatic
pressure to the kidney (P
 
K
 
). We wanted to see whether this re-
nal pressure correlated with the grade (G) of hydronephrosis—
which we defined as G 
 
 
 
 D/T, where D was the internal di-
ameter of the renal pelvis and T was the thickness of the
remaining renal parenchyma (Fig. 7, c and d). If reflux were a
main cause of hydronephrosis, there should have been a posi-
tive correlation between P
 
K
 
 and G. However, we found that
these two parameters were independent (P 
 
 
 
 0.2), which sug-
Figure 4. The UPII-deficient urothelium had small superficial cells and a
particle-free apical surface. The urothelia from age-matched 3-mo-old
wild-type (a and c) and UPII-deficient (b and d) mice were examined by
scanning EM (a and b) and quick-freeze deep etch transmission EM (c and d).
Note the replacement of large surface umbrella cells (U) by small super-
ficial cells (S) (a and b), and the complete absence of the 16-nm particles
and urothelial plaques on the apical surface of the UPII-deficient urothelium
(d). cyt, cytoplasm; m, membrane; ups, uroplakin particles. Bars: (a and b)
20  m; (c and d) 0.2  m.
Figure 5. The replacement of the fusiform vesicles by small spherical
vesicles that delivered the remaining uroplakin pair in uroplakin-deficient
urothelium. The urothelia from age-matched 3-mo-old wild-type (a, c, and d),
UPII-deficient (b, g, and h), and UPIII-deficient (e and f) mice were exam-
ined by thin section (a and b) and immunolabeling (c–h) transmission EM.
Normal uroplakin-delivering fusiform vesicles (a, c, and d) were completely
replaced by numerous small, spherical, immature-looking spherical vesicles
in UPIII-deficient (e and f) and UPII-deficient (b, g, and h) urothelia. Note
the strong labeling of normal fusiform vesicles (*) by antibodies to
uroplakins Ia (c) and Ib (d), the moderate staining of the spherical vesicles
in the UPIII-deficient urothelium (which still expressed the UPIIIb isoform;
e and f), and the weak staining of the small vesicles (arrows) in the UPII-
deficient urothelium by anti-UPIII (g) and by a rabbit antiserum to total
uroplakins (h). Arrowheads (b) indicate the smooth apical surface of the
UPII-deficient urothelium. Fv, fusiform vesicle; P, plaque; Sv, small vesicle.
Bars: (a and b) 0.5  m; (c–h) 1  m. 
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gests that reflux could not be the major etiology of hydrone-
phrosis in this system (Fig. 7 g).
Another possible cause of hydronephrosis is ureteral ob-
struction, which impedes the flow of urine from the kidney. To
investigate this possibility, we performed i.v. pyelogram (IVP)
by injecting 3 
 
 
 
l/g (of body weight) of Omnipaque into the or-
bital sinus, followed by serial radiography (Fig. 8, a and b). The
results indicated that UPII knockout mice had a significantly
delayed excretion of Omnipaque, indicating obstruction. Serial
sectioning of the urinary tracts of UPII knockout mice revealed
areas of the ureter with epithelial polyps or complete epithelial
occlusion, which caused structural obstruction (Fig. 8, c–h; see
Discussion). These results suggest that both VUR and structural
and/or functional obstruction of the ureters may be responsible
for the observed hydronephrosis in UPII knockout mice.
 
Renal dysfunction and death
 
Using a filter paper assay, we found that UPII knockout mice
had higher volume per micturition (Fig. 9 b), micturition fre-
quency (Fig. 9 c), and total urine output (Fig. 9 d) than normal
mice; no statistically significant gender differences were noted
(Fig. 9, b–d). The levels of many urinary components, including
uric acid, creatinine, potassium, sodium, and chloride ions, were
slightly reduced (Fig. 9, f–j), possibly because of defects in
mechanisms of urine concentration (Fig. 9 d). The concentration
of blood urea nitrogen (BUN) almost doubled (Fig. 9 e), suggest-
ing a compromised renal function. Interestingly, although most
of the breeding pairs yielded litters that survived into adulthood,
the litters of some breeding pairs (129/SvEv 
 
 
 
 Swiss Webster)
reproducibly died around days 8–10 postnatally (Fig. 10, a and
b). These litters were characterized by retarded growth (Fig. 10
c) and a sharp surge in the BUN level (Fig. 10 d), which suggests
renal failure as a cause of death, possibly resulting from ureteral
obstruction (Fig. 8, c– h) and a defective renal pelvis urothelium
that normally expressed uroplakins (Fig. 10 e).
 
Discussion
 
Mammalian urothelium has three unique biological features: its
apical membrane is highly specialized, harboring 2D crystals of
hexagonally packed 16-nm particles (Hicks and Ketterer, 1969;
Vergara et al., 1969; Staehelin et al., 1972; Brisson and Wade,
1983); its superficial umbrella cells are greatly flattened and ex-
panded, with a diameter reaching over 100 
 
 
 
m (Porter and Bon-
neville, 1963; Hicks, 1965; Koss, 1969; Lewis, 2000; Veranic et
al., 2004; for review see Hicks, 1975); and it is one of the slow-
est-cycling stratified epithelia, with a BrdU-labeling index of
 
 
 
0.1% (Martin, 1972; Farsund, 1975). The ablation of a single
gene that encodes uroplakin II perturbed all of these urothelial
properties and led to major urinary tract abnormalities.
 
Mechanism of uroplakin plaque formation
 
As mentioned earlier, the four major uroplakins can form two
heterodimer pairs consisting of uroplakins Ia/II and Ib/III (Wu
et al., 1995; Liang et al., 2001; Tu et al., 2002). Transfection
Figure 6. Inactivation of the UPII gene led to vesicoureteral reflux. An India
ink suspension (0.1% in PBS) was instilled into the bladders of 11 normal
3-mo--old mice and 10 UPII knockout mice, and the hydrostatic pressure at
which micturition (micturition pressure [PM]) and reflux (reflux pressure [PR])
occurred for individual ureters were recorded. Note in a the presence of
India ink in the bladder (B) and ureters (U) and, in b, in the left kidney
(K)—but not in the right kidney, suggesting obstruction of the right ureter.
Also note that, although the UPII-deficient (KO) mice had a normal micturition
pressure (c), 11 out of 20 ureters (55%) had retrograde flow of urine into
the ureters (occurring at a pressure lower than the micturition pressure; d,
closed circles), compared with 3 out of 22 ureters (13.6%) in wild-type
(WT) mice. Open circles denote cases where reflux occurred at a pressure
higher than the micturition pressure (and thus would not occur naturally).
e shows the mean values of PR based on the data shown in d. Error bars
represent 1 SD.
Figure 7. Inactivation of the UPII gene caused hydronephrosis and renal
abnormalities. The kidneys of normal (a, c, and e) and UPII-deficient (b, d,
and f) mice were compared in terms of their gross appearance (a and b),
whole kidney section (c and d), and histological appearance (e and f).
The mice used were 6 mo old for a and b, and 3 mo old for c–g. g shows
a plot of renal pressure (PM   PR) versus the grade of hydronephrosis (D/T,
where D and T were the diameter of the renal pelvis cavity and the thickness
of the renal parenchyma, respectively). More than 100 knockout mice
were studied and  80% of them showed various degrees of hydronephrosis.
Note a lack of positive correlation between the grade of hydronephrosis
and renal pressure (Pk) (t test, t   0.177, P   0.2), which suggests that
reflux could not be a major cause of hydronephrosis. (c, e, and f) C, cortex;
G, glomeruli; M, medulla; T, tubules; U, urothelium. Bar, 50  m.JCB • VOLUME 167 • NUMBER 6 • 2004 1200
studies indicated that the formation of correct heterodimer is
required for uroplakins (except UPIb; see below) to exit from
the ER and to reach the cell surface (Tu et al., 2002). Because
293T (a human embryonic kidney–derived cell line) cells were
used in these transfection studies, the physiological signifi-
cance of in vitro data obtained using nonurothelial cells might
be questioned. Our in vivo data show that although UPIa is dis-
tributed throughout the cytoplasm of the UPII-deficient urothe-
lium, suggesting ER entrapment (Fig. 3 d), uroplakins Ib and
III (of the Ib/III pair) can reach the urothelial surface (Fig. 3, f
and j). These in vivo results validate the transfection data ob-
tained using the 293T cells (Tu et al., 2002), and further sup-
port the existence of the Ia/II and Ib/III heterodimers.
Although cultured bovine urothelial cells continue to syn-
thesize large amounts of all the uroplakins, these cells do not
form any mature-looking, uroplakin-delivering fusiform vesi-
cles that are characteristic of the in vivo umbrella cells, and
their apical cell surface is completely devoid of urothelial
plaques (Surya et al., 1990; Chen et al., 2003). Based on what
we have learned from cultured keratinocytes (Weiss et al.,
1984; Schermer et al., 1989), cultured urothelial cells most
likely mimic in vivo regenerating urothelium (Surya et al.,
1990; Chen et al., 2003). The inability of regenerating urothe-
lial cells to assemble plaques could be functionally important,
because a cell surface laden with the rigid-looking plaques may
be incompatible with cell migration and proliferation during
wound repair. Therefore, although we can study certain early
steps of uroplakin interaction in the currently available, cul-
tured urothelial cells and transfected 293T cells, the final stages
of uroplakin assembly and 2D crystal formation need to be
studied using the in vivo urothelium. Our present finding that
the uroplakin II–deficient urothelium lacks 16-nm particles
(Fig. 4, c and d) indicates that, although the UPIb/III pair can
be delivered to the apical surface (Fig. 3, f and j) using the
small vesicles ( 150–200 nm in diameter) accumulated in the
UPII-deficient superficial cells (Fig. 5, b, g, and h), the UPIb/
III pair by itself cannot form the 16-nm particle, let alone the
urothelial plaques (Fig. 4 d). Severs and Hicks (1979) have
shown that, in normal urothelium, 16-nm particles can be de-
tected in early vesicles that have just budded off the Golgi ap-
paratus, which suggests that the two uroplakin heterodimers
(Ia/II and Ib/III) interact before they leave the Golgi apparatus
to form the 16-nm particle. Together, these data suggest that
uroplakins first form, in the ER, heterodimers (Tu et al., 2002),
and possibly heterotetramers; the heterotetramers then assem-
ble into the 16-nm particles in the Golgi apparatus or the trans-
Golgi network, and these particles, once reaching a sufficient
density in the post-Golgi vesicles, can then aggregate to form
small and, later, large 2D crystals.
Figure 8. Inactivation of the UPII gene caused ureteral obstruction.
I.v. pyelogram of normal (a) and UPII knockout mice (b) established de-
layed excretion of contrast in the latter. c–h show the histological sections
of the ureters of normal (c and e), UPII knockout (d and f), and UPIII knock-
out (g and h) mice. Samples were taken from proximal (c and d) or distal
(e–h) ureter. Note the formation of epithelial outgrowth filling the ureteral
lumen (f), sometimes forming a complete occlusion (h). B, bladder; EO,
epithelial occlusion; EP, epithelial plug; K, kidney; L, lumen. Bar, 50  m.
Figure 9. Inactivation of the UPII gene caused renal malfunction. (a) The
standard curve of a filter paper assay for measuring the urine volume. (b)
Volume per micturition. (c) Frequency of micturition. (d) Cumulative total
micturition volume. (e) Blood urea nitrogen (BUN). Note the twofold increase
of BUN in UPII-deficient mice (P   0.00001) compared with wild-type
mice. f–j show the urinary concentrations of uric acid (f), creatinine (g),
potassium (h), sodium (i), and chloride (j). Urine and sera from 12 wild-type
and 12 knockout 3-mo-old mice were pooled for these analyses. Error
bars represent 1 SD.UROPLAKIN FUNCTIONS • KONG ET AL. 1201
Given our current assumption that both uroplakin pairs
are required for the formation of the 16-nm particle, it was baf-
fling that the UPIII-deficient urothelium still made 2D crystals,
albeit small ones, from the 16-nm uroplakin particles (Hu et al.,
2000). However, we now know that highly purified urothelial
plaques contain a minor isoform of UPIII, which we recently
characterized (Deng et al., 2002). This 35-kD protein was
named uroplakin IIIb because it is urothelium specific, it shares
a similar transmembrane topology and significant sequence ho-
mologies with UPIII (also known as UPIIIa), and it forms a
heterodimer with UPIb, UPIIIa’s partner (Deng et al., 2002).
This newly found uroplakin IIIb, which is up-regulated in UPI-
IIa-deficient urothelium (Deng et al., 2002), should allow the
formation of small amounts of heterotetramers containing het-
erodimers UPIb/UPIIIb and UPIa/UPII. The heterodimers can
then be delivered by the 150–200-nm vesicles (Fig. 5, e and f)
and account for the formation of small surface plaques in the
UPIIIa-deficient urothelium. This interpretation is consistent
with our finding that the ablation of UPII, which does not have
a known isoform, greatly diminishes the amounts of small ves-
icle-associated uroplakins and completely abolishes the forma-
tion of the 16-nm particles (Fig. 4, c and d).
We showed previously that the ablation of UPIII led to ab-
normal synthesis and processing of UPIb, i.e., the level of UPIb
mRNA was greatly increased, whereas the amount of UPIb pro-
tein was reduced, became hypoglycosylated, and was mistar-
geted to the basal/lateral cell surface (Hu et al., 2000). Because
UPIII and UPIb were known to interact, we speculated that these
UPIb changes were caused by the removal of its partner, UPIII
(Hu et al., 2000). Our finding that UPII ablation led to a similar
up-regulation of the UPIb mRNA level (Fig. 1 C) and hypogly-
cosylation of the UPIb protein (Fig. 1 E) indicates, however, that
these UPIb changes represent a general response to a perturbed
uroplakin assembly. This may explain why, in cultured human
urothelial cells, the level of mRNA for UPIb is greatly elevated
compared with those for other uroplakins (Varley et al., 2004).
Uroplakin Ib is also unique in that it is the only uroplakin that,
when expressed alone in 293T cells, can exit from the ER to
reach the cell surface (although it is required for its partner,
UPIII, to exit from the ER [Tu et al., 2002]); and in that it is the
only uroplakin that is expressed in nonurothelial tissues, includ-
ing corneal and conjunctival epithelia (Adachi et al., 2000) and,
possibly, lung epithelium (Kallin et al., 1991; Olsburgh et al.,
2003). These data indicate that uroplakin Ib is unique among the
uroplakins in its regulation and function.
Uroplakin assembly and umbrella cell 
enlargement
Normal mouse urothelium is covered by large umbrella cells
that have an average diameter of  100  m (Hicks, 1965; Koss,
1969). The greatly enlarged superficial cells can minimize the
intercellular space, thus contributing to the permeability barrier
function of the apical urothelial surface (Negrete et al., 1996;
Zeidel, 1996; Lewis, 2000; Apodaca, 2004). The mechanism
by which these large umbrella cells, which are frequently tetra-
ploid or octoploid (Farsund, 1975), are formed is unclear, al-
though both arrested cytokinesis (Farsund, 1976; Farsund and
Dahl, 1978) and cell fusion (Martin and Wong, 1981) have
been suggested. Our finding that the superficial cells of both
UPII- and UPIII-deficient urothelia failed to enlarge (Fig. 4, a
and b; Hu et al., 2000) suggests that urothelial plaque forma-
tion may play a role in umbrella cell enlargement. It is possible
that the continued insertion of fusiform vesicles into the apical
surface not only expands (Porter and Bonneville, 1963; Hicks,
Figure 10. Inactivation of the UPII gene can
cause neonatal death of the entire litters from
some mouse breeding pairs. (a) The pedigree
of one pair of founder mice. Note that the
entire litter of pups from some breeding pairs,
but not from other pairs, died around day 10
postnatally. (b) The fractional survival curves
of two litters from different breeding pairs.
One underwent neonatal death (2KO-death),
whereas the other (2KO-health), like the nor-
mal wild-type control (WT), survived into adult-
hood. (c) The growth (increase in body
weight) of the 2KO-death mice was severely
retarded. (d) The blood urea nitrogen (BUN)
of the 2KO-death mice increased drastically
(reaching  10-fold the normal value) before
the animals’ death. (e) Immunohistochemical
staining of normal mouse kidney (embryonic
day 16.5), showing that the renal pelvis (RP)
urothelium (U) and the simple epithelium cov-
ering the papilla (arrowheads) are uroplakin
positive. Arrowheads indicate the single-layered
papillary epithelium. CD, collecting ducts.
Bar, 50  m.JCB • VOLUME 167 • NUMBER 6 • 2004 1202
1965; Koss, 1969; Staehelin et al., 1972; Lewis and de Moura,
1982; Truschel et al., 2002; Apodaca, 2004), but also alters/sta-
bilizes, the luminal surface, thus hindering cytokinesis; the fact
that some umbrella cells can incorporate BrdU (Fig. 2, c and d;
Erman et al., 2004) makes it plausible that arrested cytokinesis
could contribute to polyploidy and cell enlargement. A combi-
nation of cell surface expansion and arrested cytokinesis may
thus account for the formation of large polyploid umbrella
cells, without resorting to cell fusion. This “surface alteration
hypothesis” is supported by cell kinetic data suggesting ar-
rested cytokinesis (Farsund, 1976; Farsund and Dahl, 1978);
however, additional studies are needed to test this hypothesis.
Uroplakins and urothelial growth
A striking phenotype of both uroplakin II– and uroplakin III–
deficient urothelia is that they become hyperplastic, with a
BrdU-labeling index of  10%, versus a normal value of 0.1%
(Fig. 2, c and d) (Hu et al., 2000). It is possible that the per-
meability barrier function of the uroplakin-deficient urothelia
is compromised (Hu et al., 2002) so that the EGF-related mi-
togens that are known to be present in high concentrations in
the mouse urine (Lakshmanan et al., 1990; Parries et al.,
1995) can reach urothelial basal cells to stimulate cell prolif-
eration (Rebel et al., 1994). Alternatively, fully assembled
urothelial plaques can trigger certain growth-inhibiting sig-
nals, which are now absent in the uroplakin-deficient urothe-
lia, leading to hyperplasia. Additional studies are needed to
distinguish these possibilities.
Roles of uroplakin defects in urinary 
tract diseases
Our earlier observation that inactivation of the mouse uroplakin
III gene resulted in VUR and hydronephrosis raised the possi-
bility that uroplakin defects may cause VUR in humans (Hu et
al., 2000; Mak and Kuo, 2003). By surveying 76 VUR patients,
we identified 18 single-nucleotide polymorphisms; 7 of them
are missense, with no truncation or frameshift mutations (Jiang
et al., 2004). Only two of the missense polymorphisms (an
Ala7Val change in the UPIa gene and a Pro154Ala change in
the UPIII gene) were found to be marginally associated with
VUR (both P   0.08). These results, as well as those by Giltay
et al. (2004), suggest that the uroplakin point mutations that
have been detected so far do not play a major role in causing
VUR (Jiang et al., 2004). There are two possible explanations
for this apparent inconsistency between the human and mouse
data. First, the results of mouse studies cannot be directly ex-
trapolated to humans because of minor, but still significant, dif-
ferences in the development of the lower urinary tracts. Perhaps
for this reason, inactivation of angiotensin II receptor (AT2)
gene can cause VUR in mice (Nishimura et al., 1999), but poly-
morphisms in this gene do not seem to be involved in causing
primary familial VUR in humans (Hohenfellner et al., 1999;
Yoneda et al., 2002). Second, and perhaps more importantly, no
truncation or frameshift mutations have been detected in any of
the VUR patients that have been studied so far, and some breed-
ing pairs of the UPII and UPIII knockout mice reproducibly die
postnatally around days 8–10, as a result of renal failure (Fig.
10; Hu et al., 2000), suggesting that certain uroplakin defects
(such as deletion, truncation, or mutations in some structurally
crucial amino acid residues), in combination with certain ge-
netic backgrounds (Sanford et al., 2001; Wolfer et al., 2002),
may be embryologically or postnatally lethal and are thus unde-
tected in VUR patients. It is interesting to note that a recent sur-
vey showed that urinary tract abnormalities account for 20% of
all congenital anomalies detected during pregnancies and up to
one year after birth (Scott, 2002). Of the 560 cases of prenatal or
neonatal deaths resulting from congenital abnormalities, 58%
were because of renal anomalies, including a significant number
with obstruction (Scott, 2002).
An important finding of this study is that urothelial ab-
normalities caused by uroplakin defects can lead to renal fail-
ure and death (Fig. 10). There are several possible mechanisms
by which this could occur. First, defects in the uroplakin-posi-
tive renal pelvis urothelium, as well as in the simple epithelium
that covers the renal papilla expressing uroplakin prenatally
(Fig. 10 e; Jiang et al., 2004), may lead to renal dysfunction
and failure. Second, urothelial hyperplasia can cause obstruc-
tion of the ureteral lumen (Fig. 8, f and h). Although it has
been well-established that mechanical obstruction can induce
urothelial hyperplasia (Monson et al., 1992; Curhan et al.,
2000), it is unclear whether urothelial hyperplasia, per se, can
cause obstruction. In our system, urothelial hyperplasia seems
to be the cause, rather than the effect, of obstruction because
(a) urothelial hyperplasia precedes obstruction and hydrone-
phrosis; and (b) although only 70–80% of the mice develop hy-
dronephrosis, 100% of the animals show urothelial hyperplasia
throughout the urinary tract, thus ruling out obstruction as a
cause of urothelial hyperplasia (but see Gamp et al., 2003).
Third, defects in the ureteral urothelium may interfere with the
development of its underlying smooth muscle (Master et al.,
2003), leading to abnormal peristalsis or functional obstruction
(Santicioli and Maggi, 1998)—a possibility supported by our
recent finding that uroplakin defects lead to abnormal bladder
muscle contractility and/or function (Christ, G., personal com-
munication). These possible mechanisms, or a combination
thereof, may cause a functional/structural obstruction of the
urinary tract, leading to abnormal renal development (Chung
and Chevalier, 1996), obstructive nephropathy, hydronephro-
sis, and, in severe cases, renal failure and death.
Materials and methods
Production of the UPII knockout mice
Genomic clones of the mouse UPII gene were isolated from a 129/Ola
mouse P1 genomic library (Genome Systems). The targeting vector was
designed to delete the first four exons, and a part of the fifth, of the UPII
gene (Fig. 1 A). Three primers were used for genotyping; one forward (5 -
gagggagttaagactcaagaatcaatcaagga-3 ) and two reverse (5 -cttctatcgcct-
tcttgacgagttcttctgagg-3  for detecting a 3.8-kb product of the neomycin se-
quence, and 5 -cagatttctagcagtccactcttgtagaacgg-3  for a 4.0-kb product
of the native UPII gene; Fig. 1, A and B).
Morphological studies
Mouse urothelium was examined by scanning EM (model JSM-840; JEOL)
and transmission EM (model 200CX; JEOL) (Hu et al., 2000). Quick-freeze
deep etch was performed as described previously (Kachar et al., 1999).
Cell proliferation was assessed based on the nuclear incorporation of BrdU
(Sigma-Aldrich). 19-d-old mice received five intraperitoneal injections ofUROPLAKIN FUNCTIONS • KONG ET AL. 1203
BrdU (100 mg/kg of body weight, in PBS), 1.5 h apart, and were killed
2 h after the final injection. Various tissues, including esophagus and urinary
bladder tissues, were removed, fixed in 10% formalin overnight, and pro-
cessed for immunostaining with a horseradish peroxidase–conjugated anti-
BrdU monoclonal antibody (CHEMICON International). Samples were visu-
alized with a microscope (Axiophot; Carl Zeiss MicroImaging, Inc.) with
10 /0.32 and 20 /0.60 (Plan-Apochromat) or 40 /0.75 (Plan-Neo-
fluar) objective lenses. Images were captured with a digital camera (model
DKC-5000; Sony) at room temperature. The images were processed in size
and contrast/brightness with Adobe Photoshop 6.0.
Isolation of detergent-insoluble proteins from mouse urothelium
Mouse urothelial cells were homogenized in buffer A (10 mM Hepes, pH
7.5, 1 mM EDTA, 1 mM EGTA, and 1 mM PMSF), loaded onto a 1.6-M su-
crose cushion (in buffer A), and centrifuged at 16,000 rpm for 25 min at
4 C (SW41; Beckman Coulter). The crude membranes concentrated at the
interface were isolated, washed with buffer A, treated with 2% Sarkosyl in
buffer A for 10 min at 25 C, and pelleted. The detergent-insoluble mem-
branes, in which the urothelial plaques were highly enriched, were washed
with buffer A before they were solubilized in SDS-PAGE sample buffer and
analyzed by SDS-PAGE, followed by silver nitrate staining, or by immuno-
blotting (Wu et al., 1994; Liang et al., 1999; Zhou et al., 2001).
Determination of reflux pressure and hydronephrosis
The reflux pressure was recorded as the hydrostatic pressure (i.e., cm of
H2O) at which an India ink suspension in PBS backflowed from the blad-
ders into the ureters of anesthetized mice (Hu et al., 2000). At the end of
the experiment, the kidneys were dissected longitudinally to confirm the
presence of the ink in the renal pelvis (Fig. 6 b).
Determination of the micturition pattern and urine/blood chemistry
The micturition pattern of the mice was recorded using special cages, as
described previously (Hu et al., 2000). A total of  500  l of mouse urine
was collected from each mouse and used for assaying the concentrations
of uric acid, creatinine, potassium, sodium, and chloride ions (Tufts Veteri-
nary Diagnostic Laboratory). Mouse sera were used for assaying the BUN
level (Anilytics).
Determination of obstruction by IVP and serial sectioning of the mouse ureter
IVP was performed in anesthetized 4-mo-old wild-type (n    2) and
uroplakin II–deficient (n   4) mice. The contrast Omnipaque (Iohexol; 3
 l/g of body weight) was injected into the orbital sinus, and serial radio-
graphs were made at 0, 5, 15, 30, 45, 60, and 90 min. After lethal anes-
thesia, the urinary tracts were dissected and fixed in 10% formalin over-
night. The ureters were embedded in paraffin and serially sectioned.
Sections were numbered from superior to inferior orientation and stained
with hematoxylin and eosin.
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